This article announces that Visa Inc. Class A has filed a Form 8K on September 11. It's a brief news item indicating a regulatory filing by the company. The content primarily consists of navigation links and stock market data rather than detailed information about the filing itself.

Pool Corporation's stock has dropped to a 52-week low of $172.62, marking a 49% decline from its high and a 46.95% decrease over the past year. Despite this downturn and downward revisions from analysts, InvestingPro suggests the stock is undervalued, highlighting its 15 consecutive years of dividend increases. The company recently reported mixed Q2 2026 results with earnings exceeding estimates but revenue falling short, leading to cautious analyst ratings and reduced price targets.

This article reports that Regency Centers Corp (REG) filed a Form 8K on September 11. The brief entry provides the filing information and notes the stock's performance at -0.21%. No further details regarding the content of the Form 8K are included in the provided text.

Chevron CEO Mike Wirth warned that the buffers against rising oil prices have been depleted, making it more likely that crude prices will increase in the coming months. He noted that countries had released strategic crude stockpiles and the US had lifted restrictions on oil from sanctioned countries, but these measures are now exhausted. Wirth also discussed Chevron's operations near the conflict zone and its planned expansion in Venezuela, while the IEA reported a significant drop in global oil inventories.

Colgate-Palmolive is reportedly considering selling several mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, in a deal estimated to be worth up to $1 billion. This potential divestment, for which Goldman Sachs is advising, aims to streamline Colgate's portfolio, allowing the company to concentrate on stronger brands amidst increasing costs and tariff pressures. The move aligns with a broader trend among consumer goods companies reassessing their assets to optimize capital and management focus.

EOG Resources CEO Ezra Yacob stated that geopolitical risks in the Middle East have not changed the company's assessment of its unconventional oil and gas prospects in the UAE and Bahrain. Yacob emphasized that the commercial viability of these projects depends more on the operating environment and subsurface derisking rather than regional geopolitical instability. This indicates a focus on geological and operational factors over political ones for their Mideast investments.

Energy Transfer, a $100 billion pipeline company, is moving its primary stock listing from the New York Stock Exchange to the Dallas-based Texas Stock Exchange (TXSE). This move marks a significant win for TXSE, which aims to challenge the virtual duopoly of NYSE and Nasdaq and establish Texas as a global capital markets leader. The company expects to begin trading on TXSE on October 5, aligning its Texas roots with the new exchange's platform.

Chevron CEO Mike Wirth warned that oil prices are likely to remain elevated in the coming months due to the depletion of supply buffers that previously softened the impact of the U.S.-Iran conflict. He stated that the risks to oil prices remain on the upside, with Brent crude having already surged over 50% since the Middle East war began. Chevron plans to invest $7 billion in its Venezuelan operations, aiming to more than double production by 2031, funded by existing ventures in the country.

Amgen reported a 26% year-over-year growth in its six key commercial drivers, contributing to a 10% increase in total revenue, exceeding $10 billion. The company highlighted significant advancements for its oncology drug IMDELLTRA, including improved overall survival in a Phase III study for small cell lung cancer, and is seeking to reduce patient monitoring requirements to improve access. Amgen also detailed the promising potential of MariTide for obesity and related conditions, noting its differentiated dosing schedule, substantial weight loss in Phase II, and possible cardiovascular benefits, with Phase III studies underway for various indications.

Deere (DE) and Caterpillar (CAT) stocks have surged by 47% and 44% year-to-date, respectively, significantly outperforming the broader industrial sector and the S&P 500. This narrow rally prompts investors to decide whether to take profits or hold their positions, as the gains are company-specific rather than a sector-wide re-rating. While taking profits addresses the concentration risk and less attractive reward-to-risk for new money, holding on is supported by the continued momentum and the fact that neither stock has shown a sell signal, attracting benchmark-driven investments.